COVID-19: WHO Suspends Trials of Hydroxychloroquine

10

The World Health Organization (WHO) said testing of the malaria drug hydroxychloroquine as a possible treatment for coronavirus has been halted because of safety fears.

Trials in several countries are being temporarily suspended as a precaution.

It comes after a recent medical study suggested the drug could increase the risk of patients dying from COVID-19.

United States President Donald Trump has promoted the anti-malarial drug, despite warnings from public health officials that it could cause heart problems in COVID-19 patients.

Trump also said he was taking the drug himself to ward off the virus, but said in Sunday he was not taking it any more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

four × 1 =

This site uses Akismet to reduce spam. Learn how your comment data is processed.